Assembly Biosciences (ASMB)
(Delayed Data from NSDQ)
$12.65 USD
-0.71 (-5.31%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $12.39 -0.26 (-2.06%) 7:58 PM ET
2-Buy of 5 2
C Value A Growth B Momentum A VGM
Price, Consensus and EPS Surprise
ASMB 12.65 -0.71(-5.31%)
Will ASMB be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for ASMB based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for ASMB
Are Medical Stocks Lagging ASLAN Pharmaceuticals (ASLN) This Year?
TEVA Shares Rise on Broad Support for Opioids Settlement
ASMB: What are Zacks experts saying now?
Zacks Private Portfolio Services
After Plunging 17% in 4 Weeks, Here's Why the Trend Might Reverse for Assembly Biosciences (ASMB)
Assembly Biosciences (ASMB) Upgraded to Strong Buy: Here's Why
Best Momentum Stocks to Buy for August 4th
Other News for ASMB
Analysts Offer Insights on Healthcare Companies: Assembly Biosciences (ASMB), Natera (NTRA) and Disc Medicine (IRON)
H.C. Wainwright Sticks to Its Hold Rating for Assembly Biosciences (ASMB)
Assembly Biosciences Reports Fourth Quarter and Year End 2023 Financial Results and Recent Highlights
ASMB Stock Earnings: Assembly Biosciences Beats EPS for Q4 2023
Assembly Biosciences GAAP EPS of -$13.38 beats by $0.90